medicine3 papersavg year 2026weak evidence

Substantial progress has been made in understanding

Research gap analysis derived from 3 medicine papers in our local library.

The gap

Although substantial progress has been made in understanding the roles of gut microbiota, probiotics, and TCM in CHD, several priorities remain before this field can move from mechanistic insight to clinically actionable intervention. Future

Evidence profile

Stated in the future work and cells future research sections of the source papers, classified as general, spanning 3 journals.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 3 representative gaps

  • Traditional Chinese medicine–based modulation of gut microbiota in coronary heart disease: probiotic synergy and translational perspectives (2026) · Frontiers in Cardiovascular Medicine · doi

    Although substantial progress has been made in understanding the roles of gut microbiota, probiotics, and TCM in CHD, several priorities remain before this field can move from mechanistic insight to clinically actionable intervention. Future work should focus on five directions: AI-assisted systems interdisciplinary platform modeling, precision stratification, construction, integration of microbiome regulation into secondary prevention frameworks.

    generalstated in future workevidence 5/5
    Keywords: substantial progress made understanding roles microbiota probiotics several priorities remain move mechanistic insight clinically actionable
  • Editorial: Microbiota, antibiotic resistance, and host-microbe interactions: a comprehensive exploration of infectious disease dynamics (2026) · Frontiers in Cellular and Infection Microbiology · doi

    Advances in multi-omics technologies, metagenomics, artificial intelligence, and systems biology are facilitating a more compre- hensive understanding of host–microbe interactions and microbial ecosystem dynamics (Hasin et al., 2017; The Integrative HMP (iHMP) Research Network Consortium, 2019). These approaches have the potential to accelerate the development of precision medicine strategies that integrate microbiome profiles, host immune responses, and pathogen characteristics to improve disease prediction and therapeutic outcomes.

    generalstated in future workevidence 5/5
    Keywords: host advances multi omics technologies metagenomics arti cial intelligence systems biology facilitating compre hensive understanding
  • Host-microbiome-immune disequilibrium in oral disease: mechanisms, dysbiosis, and precision therapeutics (2026) · Frontiers in Immunology · doi

    The authors suggest that future research should focus on integrating evidence from microbiome ecology, mucosal immunology, disease pathogenesis, and translational research. - The paper highlights the need for large, long-term studies and trials to test the effectiveness of microbiome-based or host-microbiome methods in improving diagnosis, prediction, or treatment. - The authors emphasize the potential of emerging technologies, including microbiome-modulating therapies and artificial intelligence, in reshaping the field.

    generalstated in cells future researchevidence 5/5
    Keywords: authors suggest future research focus integrating evidence microbiome

Questions about this gap

Although substantial progress has been made in understanding the roles of gut microbiota, probiotics, and TCM in CHD, several priorities remain before this field can move from mecha… This is supported by 3 representative gap statements extracted from 3 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.

Related gaps in Medicine

Command palette

Jump anywhere, run any action.